These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20937756)

  • 21. [Gene tests in cardiac rhythm disturbances--new international expert recommendations].
    Swan H
    Duodecim; 2012; 128(7):697-704. PubMed ID: 22612020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Hershberger RE; Cowan J; Morales A; Siegfried JD
    Circ Heart Fail; 2009 May; 2(3):253-61. PubMed ID: 19808347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of genetics in the clinical evaluation of cardiomyopathy.
    Judge DP
    JAMA; 2009 Dec; 302(22):2471-6. PubMed ID: 19996403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Hitomi N; Kubo T; Kitaoka H; Hirota T; Hamada T; Hoshikawa E; Hayato K; Okawa M; Kimura A; Doi YL
    J Cardiol; 2010 Sep; 56(2):189-96. PubMed ID: 20605413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?
    Roden DM; Hong CC
    Circulation; 2013 Apr; 127(16):1641-3. PubMed ID: 23519759
    [No Abstract]   [Full Text] [Related]  

  • 26. Familial occurrence in cardiovascular diseases. Familial cardiovascular diseases (1).
    Sangiorgi M; Fragola PV; Capria A
    Ann Ital Med Int; 1989; 4(1):32-9. PubMed ID: 2702015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy.
    Smolik S; Domal-Kwiatkowska D; Kapral M; Weglarz L
    Acta Pol Pharm; 2010; 67(6):669-72. PubMed ID: 21229884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy.
    Elliott P; O'Mahony C; Syrris P; Evans A; Rivera Sorensen C; Sheppard MN; Carr-White G; Pantazis A; McKenna WJ
    Circ Cardiovasc Genet; 2010 Aug; 3(4):314-22. PubMed ID: 20716751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
    Keren A; Syrris P; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetics of inherited cardiomyopathies].
    Richard P; Fressart V; Charron P; Hainque B
    Pathol Biol (Paris); 2010 Oct; 58(5):343-52. PubMed ID: 19942368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epinephrine QT stress testing in congenital long QT syndrome.
    Vyas H; Ackerman MJ
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S107-13. PubMed ID: 16962127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic impact of genetic testing in hypertrophic cardiomyopathy: The story of two families.
    Lorca R; Martín M; Gómez J; Junquera MR; Morís C; Coto E; Reguero JJR
    Int J Cardiol; 2016 Feb; 205():161-162. PubMed ID: 26736093
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genetic counseling in congenital long QT syndrome].
    Hamang A; Solberg B; Bjorvatn C; Greve G; Øyen N
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1226-9. PubMed ID: 19521446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Making genetics not so important: family work in dealing with familial hypertrophic cardiomyopathy.
    Geelen E; Van Hoyweghen I; Horstman K
    Soc Sci Med; 2011 Jun; 72(11):1752-9. PubMed ID: 20630643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misdiagnosis of long QT syndrome as epilepsy at first presentation.
    MacCormick JM; McAlister H; Crawford J; French JK; Crozier I; Shelling AN; Eddy CA; Rees MI; Skinner JR
    Ann Emerg Med; 2009 Jul; 54(1):26-32. PubMed ID: 19282063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.
    Austin SE; Hegele RA
    Can J Cardiol; 2011; 27(6):682-4. PubMed ID: 21652171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A contemporary approach to hypertrophic cardiomyopathy.
    Ho CY; Seidman CE
    Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of molecular genetics in cardiac diseases.
    Schwartz K
    Herz; 1994 Apr; 19(2):69-74. PubMed ID: 8194834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics, genomics, proteomics: what is a cardiologist to do?
    Califf RM
    Am Heart J; 2000 Oct; 140(4):S48-50. PubMed ID: 11011324
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital long QT syndromes: clinical features, molecular genetics and genetic testing.
    Ching CK; Tan EC
    Expert Rev Mol Diagn; 2006 May; 6(3):365-74. PubMed ID: 16706739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.